3.0
Jul 16, 2021
Former employee
Recommend
CEO approval
Business outlook
Pros
Great culture before buy out. The clinical data was already there so all we had to do was launch the product. Easy, right?!
Cons
- Not so great culture after buy out - R&D not strong. Data was already there for their one product that they intended to launch. - Mfg Management relatively disconnected - Experience is really nothing worthwhile or cutting edge that you couldn't get somewhere else